• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CT 引导经皮射频消融治疗不可切除肺肿瘤后局部进展的决定因素:单中心 9 年经验。

Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.

机构信息

Department of Radiology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.

出版信息

Cardiovasc Intervent Radiol. 2010 Aug;33(4):787-93. doi: 10.1007/s00270-009-9770-9. Epub 2009 Dec 5.

DOI:10.1007/s00270-009-9770-9
PMID:19967367
Abstract

The purpose of this study was to retrospectively determine the local control rate and contributing factors to local progression after computed tomography (CT)-guided radiofrequency ablation (RFA) for unresectable lung tumor. This study included 138 lung tumors in 72 patients (56 men and 16 women; age 70.0 +/- 11.6 years (range 31-94); mean tumor size 2.1 +/- 1.2 cm [range 0.2-9]) who underwent lung RFA between June 2000 and May 2009. Mean follow-up periods for patients and tumors were 14 and 12 months, respectively. The local progression-free rate and survival rate were calculated to determine the contributing factors to local progression. During follow-up, 44 of 138 (32%) lung tumors showed local progression. The 1-, 2-, 3-, and 5-year overall local control rates were 61, 57, 57, and 38%, respectively. The risk factors for local progression were age (>or=70 years), tumor size (>or=2 cm), sex (male), and no achievement of roll-off during RFA (P < 0.05). Multivariate analysis identified tumor size >or=2 cm as the only independent factor for local progression (P = 0.003). For tumors <2 cm, 17 of 68 (25%) showed local progression, and the 1-, 2-, and 3-year overall local control rates were 77, 73, and 73%, respectively. Multivariate analysis identified that age >or=70 years was an independent determinant of local progression for tumors <2 cm in diameter (P = 0.011). The present study showed that 32% of lung tumors developed local progression after CT-guided RFA. The significant risk factor for local progression after RFA for lung tumors was tumor size >or=2 cm.

摘要

本研究旨在回顾性确定 CT 引导下射频消融(RFA)治疗不可切除肺部肿瘤后局部控制率和局部进展的相关因素。该研究纳入了 72 名患者(56 名男性和 16 名女性)共 138 个肺部肿瘤,年龄 70.0±11.6 岁(范围 31-94 岁);平均肿瘤大小 2.1±1.2cm(范围 0.2-9cm),这些患者均在 2000 年 6 月至 2009 年 5 月期间接受了肺部 RFA 治疗。患者和肿瘤的中位随访时间分别为 14 个月和 12 个月。计算局部无进展生存率和总生存率,以确定局部进展的相关因素。随访期间,138 个肺部肿瘤中有 44 个(32%)出现局部进展。1、2、3 和 5 年总局部控制率分别为 61%、57%、57%和 38%。局部进展的危险因素为年龄(≥70 岁)、肿瘤大小(≥2cm)、性别(男性)和 RFA 时未达到卷边(P<0.05)。多因素分析发现肿瘤大小≥2cm 是局部进展的唯一独立因素(P=0.003)。对于肿瘤直径<2cm 的患者,68 例中有 17 例(25%)出现局部进展,1、2 和 3 年的总局部控制率分别为 77%、73%和 73%。多因素分析发现,年龄(≥70 岁)是肿瘤直径<2cm 患者局部进展的独立决定因素(P=0.011)。本研究表明,CT 引导下 RFA 治疗后 32%的肺部肿瘤出现局部进展。RFA 治疗肺部肿瘤后局部进展的显著危险因素是肿瘤直径≥2cm。

相似文献

1
Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.CT 引导经皮射频消融治疗不可切除肺肿瘤后局部进展的决定因素:单中心 9 年经验。
Cardiovasc Intervent Radiol. 2010 Aug;33(4):787-93. doi: 10.1007/s00270-009-9770-9. Epub 2009 Dec 5.
2
Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers.非手术临床N0期非小细胞肺癌的经皮肺热消融:两个中心87例患者的八年经验结果
Cardiovasc Intervent Radiol. 2015 Feb;38(1):160-6. doi: 10.1007/s00270-014-0999-6. Epub 2014 Nov 14.
3
Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.肺肿瘤经皮射频消融术后局部肿瘤进展发生的危险因素。
Diagn Interv Radiol. 2007 Dec;13(4):199-203.
4
The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.射频消融治疗肝细胞癌(>2cm 且<5cm)所需的最小消融边界以预防局部肿瘤进展:使用 CT 图像融合的 3D 定量评估。
AJR Am J Roentgenol. 2010 Sep;195(3):758-65. doi: 10.2214/AJR.09.2954.
5
Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.胸外科对476例连续患者进行CT引导下肺肿瘤射频消融的长期观察:单机构经验
Acad Radiol. 2017 Dec;24(12):1517-1525. doi: 10.1016/j.acra.2017.06.018. Epub 2017 Sep 6.
6
Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.CT引导下经皮肺肿瘤射频消融术后导致空洞形成的因素。
J Vasc Interv Radiol. 2007 Mar;18(3):399-404. doi: 10.1016/j.jvir.2007.01.004.
7
Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.经皮射频消融肺肿瘤后局部进展的危险因素:基于147例肿瘤回顾性研究的评估
J Vasc Interv Radiol. 2017 Apr;28(4):481-489. doi: 10.1016/j.jvir.2016.11.042. Epub 2017 Jan 19.
8
Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.经皮影像引导微波消融与冷冻消融治疗肉瘤肺转移瘤的比较:10 年经验。
AJR Am J Roentgenol. 2022 Mar;218(3):494-504. doi: 10.2214/AJR.21.26551. Epub 2021 Oct 6.
9
Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?重复射频消融治疗肺部肿瘤局部进展:其在局部肿瘤控制中是否发挥作用?
J Vasc Interv Radiol. 2008 May;19(5):706-11. doi: 10.1016/j.jvir.2007.12.441. Epub 2008 Mar 17.
10
Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy.复发性非小细胞肺癌:CT引导下射频消融作为挽救性治疗的评估
Acta Radiol. 2012 Oct 1;53(8):893-9. doi: 10.1258/ar.2012.110333. Epub 2012 Sep 7.

引用本文的文献

1
Role of Repeated Radiofrequency Ablation for Patients with Lung Metastases of Head and Neck Adenoid Cystic Carcinoma: Long-term Single-center Study in 16 Patients with 289 Tumors.重复射频消融术在头颈部腺样囊性癌肺转移患者中的作用:对16例患者289个肿瘤的单中心长期研究
Interv Radiol (Higashimatsuyama). 2025 Feb 7;10:e20240015. doi: 10.22575/interventionalradiology.2024-0015. eCollection 2025 Mar 28.
2
CT-based radiomics and cluster analysis for the prediction of local progression in stage I NSCLC patients treated with microwave ablation.基于CT的影像组学和聚类分析用于预测接受微波消融治疗的I期非小细胞肺癌患者的局部进展
iScience. 2024 Dec 9;28(1):111552. doi: 10.1016/j.isci.2024.111552. eCollection 2025 Jan 17.
3
Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study.
立体定向消融放疗与经皮微波消融治疗早期非小细胞肺癌:一项多中心回顾性研究。
BMC Cancer. 2024 Mar 6;24(1):304. doi: 10.1186/s12885-024-12055-6.
4
A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy.用于预测接受影像引导微波消融联合化疗的晚期非小细胞肺癌患者无进展生存期的预后模型。
Eur Radiol. 2023 Nov;33(11):7438-7449. doi: 10.1007/s00330-023-09804-9. Epub 2023 Jun 15.
5
Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.立体定向体部放疗与射频消融治疗早期非小细胞肺癌的比较:一项系统评价和荟萃分析
Ann Transl Med. 2022 Jan;10(2):104. doi: 10.21037/atm-21-6256.
6
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors.非小细胞肺癌的热消融:治疗方式综述及与免疫检查点抑制剂联合应用的证据
Transl Lung Cancer Res. 2021 Jun;10(6):2842-2857. doi: 10.21037/tlcr-20-1075.
7
Magnetic resonance imaging-guided microwave ablation for lung tumor: a case report.磁共振成像引导下微波消融治疗肺肿瘤:一例报告
Quant Imaging Med Surg. 2021 Jun;11(6):2780-2784. doi: 10.21037/qims-20-667.
8
Percutaneous radiofrequency ablation for hepatic tumors: factors affecting baseline impedance.经皮射频消融治疗肝肿瘤:影响基础阻抗的因素。
Diagn Interv Radiol. 2021 May;27(3):386-393. doi: 10.5152/dir.2021.19605.
9
Advances in study of the sequence of lung tumor biopsy and thermal ablation.肺肿瘤活检和热消融序列研究进展。
Thorac Cancer. 2021 Feb;12(3):279-286. doi: 10.1111/1759-7714.13795. Epub 2020 Dec 28.
10
Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.立体定向体部放疗与经皮局部肿瘤消融治疗早期非小细胞肺癌的比较。
Lung Cancer. 2019 Dec;138:6-12. doi: 10.1016/j.lungcan.2019.09.009. Epub 2019 Sep 16.